Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2025-11-12 00:00:00 ET · period of report 2025-11-07 · accession 0001104659-25-110430 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-11-12 | 2025-11-07+ | RYTM | Cramer Pamela J. | CHRO | S - Sale+OE | $99.00 | -22.9K | 20.8K | -52% | -$2.26M |
| DM | 2025-11-12 | 2025-11-07+ | RYTM | Cramer Pamela J. | CHRO | M - OptEx | $11.51 | +22.9K | 29.6K | +339% | +$263.1K |
| DM | 2025-11-12 | 2025-11-07+ | RYTM | Cramer Pamela J. | CHRO | M - OptEx | $0.00 | -22.9K | 7,035 | -76% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-10 | S | D | 3,515 | $100.00 | 20,814 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-10 | M | A | 3,515 | $6.80 | 24,329 | D | — | — | |
| 3 | Common | Common Stock | 2025-11-07 | M | A | 10,546 | $6.80 | 40,165 | D | — | — | |
| 4 | Common | Common Stock | 2025-11-07 | S | D | 19,351 | $98.82 | 20,814 | D | — | — | |
| 5 | Common | Common Stock | 2025-11-07 | M | A | 8,805 | $19.02 | 29,619 | D | — | — | |
| 6 | Derivative | Stock Options (Right to Buy) | 2025-11-10 | M | D | 3,515 | $0.00 | 3,520 | D | $6.80 · — to 2032-02-08 | 3,515 Common Stock | (F3) The stock options were granted on February 9, 2022. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. |
| 7 | Derivative | Stock Options (Right to Buy) | 2025-11-07 | M | D | 8,805 | $0.00 | 5,257 | D | $19.02 · — to 2031-07-25 | 8,805 Common Stock | (F2) The stock option is fully vested. |
| 8 | Derivative | Stock Options (Right to Buy) | 2025-11-07 | M | D | 10,546 | $0.00 | 7,035 | D | $6.80 · — to 2032-02-08 | 10,546 Common Stock | (F3) The stock options were granted on February 9, 2022. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. |